chr10-27100439-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014915.3(ANKRD26):c.-113A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000761 in 1,314,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014915.3 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- thrombocytopenia 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
 - acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - autosomal thrombocytopenia with normal plateletsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 34 
GnomAD4 exome  AF:  7.61e-7  AC: 1AN: 1314174Hom.:  0  Cov.: 21 AF XY:  0.00  AC XY: 0AN XY: 651692 show subpopulations 
Age Distribution
GnomAD4 genome  Cov.: 34 
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at